Greenridge Exploration acquires Raven Uranium Project in Saskatchewan, Canada
The project comprises four mineral claims spread over 6,269 hectares (ha) and is located near the McArthur River Uranium Mine.
The Raven Uranium Project, now 100% owned by Greenridge, is positioned near the eastern margin of the Athabasca Basin, around 65km south-east of the McArthur River Uranium Mine.
Greenridge Exploration's acquisition includes new claims that are contiguous to a single claim already in the company's possession.
Raven is characterised by more than 9km of a historical electromagnetic conductor aligned with a magnetic low, indicative of potential uranium mineralisation.
The region is known for its structural trends, which, when intersected by brittle faults, are considered highly prospective for uranium deposits. Despite its promising features, Raven has no known historical drill-holes, leading Greenridge to consider the property under-explored.
Greenridge possesses data from a 2021 high-resolution airborne magnetic and radiometric survey conducted over Raven.
This technology previously aided in the discovery of uranium-bearing boulders at Patterson Lake, leading to the notable Triple R find in November 2012.
Although follow-up prospecting based on historical radiometric surveys has been limited, the company has recommended conducting further surface work.
The company is considering a helicopter-borne electromagnetic survey in 2025, which may coincide with other planned surveys in the area.
In October of the previous year, Greenridge Exploration signed a binding agreement to acquire ALX Resources, marking a strategic move to become a dominant player in the Canadian uranium exploration sector.
This merger creates a combined entity with interests in 16 uranium exploration projects covering approximately 220,000ha across the Athabasca Basin, Thelon Basin and Elliot Lake.
"Greenridge Exploration acquires Raven Uranium Project in Saskatchewan, Canada" was originally created and published by Mining Technology, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
an hour ago
- Business Insider
AI Analyst Predicts 50% Upside for HIMS Stock While Wall Street Stays Cautious
While Wall Street analysts remain cautious on Hims & Hers Health (HIMS), TipRanks' A.I. Stock Analysis tool shows strong confidence in the telehealth company's growth. Notably, TipRanks' AI sets a price target of $72 for HIMS stock, implying a 50% upside from current levels, compared with the Wall Street average of $49.11, which indicates only about 2.4% potential growth. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. For context, TipRanks' A.I. Stock Analysis delivers automated, data-driven evaluations of stocks based on key performance metrics, giving investors a clear and concise snapshot of a stock's potential. Notably, HIMS earns a strong score of 74 out of 100 on the tool. AI Analyst Highlights Earnings and Positive Outlook Hims & Hers Health's A.I. score highlights recent Q2 financials and an overall positive outlook. The earnings call showcased solid revenue and subscriber growth, along with expansion into new markets and healthcare services. Notably, Hims & Hers Health saw its subscriber count rise 31% to 2.4 million in Q2. Meanwhile, adjusted EBITDA more than doubled, reaching $82.2 million. On the downside, the company faced challenges, including a drop in GLP‑1 revenue, negative free cash flow, and rising G&A and technology expenses. Specifically, the company's free cash flow took a significant hit, dropping to a negative $69.4 million as of June 30, 2025, compared with a positive $47.6 million a year earlier. The A.I. tool also provides a summary of the company's recent earnings, highlighting both positive and negative updates. A screenshot is shown below for reference. Overall, the A.I. tool sees past the recent short-term volatility. With a growing customer base, new offerings, and market expansion, the current dip could be a buying opportunity for investors focused on the bigger picture. Wall Street Remains Cautious on HIMS Stock After the earnings release, Wall Street remains cautious on HIMS stock. Needham's four-star-rated analyst Ryan MacDonald maintained his Hold rating. He noted that the company's upcoming hormonal health launch and Canadian expansion in 2026 offer growth potential. However, he is concerned that the near-term performance is still heavily tied to weight-loss products, which face regulatory uncertainty. Meanwhile, BofA's top-rated analyst Allen Lutz maintained his Sell rating on HIMS at a price target of $28, predicting a downside of over 40%. Lutz stated that the company is dealing with several short-term challenges, including slow growth in its core business, which could put additional pressure on the GLP-1 segment. He believes that the second half of the year may be even tougher, and near-term cash flow is expected to remain limited as investments continue. Is HIMS Stock a Good Buy? Overall, Wall Street analysts have a Hold consensus rating on HIMS stock based on two Buys, seven Holds, and two Sells assigned in the last three months. The average HIMS stock price target of $49.11 implies an upside of 2.4% from the current trading level.
Politico
2 hours ago
- Politico
Canadian approval of Washington crashes under Trump
The drop in support for the U.S. government comes as Trump has engaged in a protracted battle with America's northern neighbor, hitting Canada with steep import tariffs and floating the idea of annexing the country, a proposal that sparked fierce backlash among Canadian citizens and leadership. Less than half of Canadians have generally approved of U.S. leadership since 2017. But Canadians warmed to Washington under the Biden administration, with U.S. leadership briefly receiving a net-positive approval rating in 2021. At the same time, Canadians' approval of their own leadership rose nearly 20 percentage points from last year, with nearly 60 percent of Canadians approving of the country's leaders following Prime Minister Mark Carney's April election win. Carney has taken a more conciliatory approach to the Trump administration, privately courting Trump in his attempts to secure a trade truce even as he has publicly pushed back on the White House's aggressive stance toward Canada. The poll was conducted by telephone from May 20-June 30, 2025 with a random sample of approximately 1,014 Canadian adults. The margin of sampling error is plus or minus 3.6 percentage points.
Business Insider
3 hours ago
- Business Insider
Canadian News Publishers Sound the Alarm on Google (GOOGL) AI Summaries
News publishers across Canada are raising concerns about artificial intelligence (AI) summaries produced by the Google (GOOGL) search engine. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Specifically, newspapers and broadcast media outlets say the AI-generated summaries that top many Google search results are cutting into their online traffic and further eroding their struggling businesses. Some publishers in Canada are claiming that the AI summaries produced by Google are inaccurate. When Google rolled out its AI Overview feature in 2024, its mistakes made headlines around the world. However, many of those inaccuracies have since been corrected and analysts who cover Alphabet, the parent company of Google, seem to agree that the AI-generated search summaries are now reliable. At the bottom of its AI summaries, Google warns users that 'AI responses may include mistakes.' Media Landscape Still, that hasn't stopped news publishers in Canada from levying criticism at AI as it erodes the traditional news business. Paul Deegan, CEO of News Media Canada, which represents Canadian news publishers, says AI summaries are a drag on media companies' online engagement. 'Zero clicks is zero revenue for the publisher,' said Deegan in a recent interview with The Canadian Press newswire. Canada's federal government passed the 'Online News Act' in 2023 to require U.S. technology giants such as Meta Platforms (META) Google started making payments under the legislation. However, the future of that legislation seems uncertain as Canadian Prime Minister Mark Carney has said that he is open to repealing it. Is GOOGL Stock a Buy? The stock of Alphabet has a consensus Strong Buy rating among 36 Wall Street analysts. That rating is based on 27 Buy and nine Hold recommendations issued in the last three months. The average GOOGL price target of $217.25 implies 6.88% upside from current levels.
